ABVC
Price:
$0.5488
Market Cap:
$7.12M
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression ...[Read more]
Industry
Biotechnology
IPO Date
2004-11-10
Stock Exchange
NASDAQ
Ticker
ABVC
According to ABVC BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.34. This represents a change of 11.14% compared to the average of 0.31 of the last 4 quarters.
The mean historical Current Ratio of ABVC BioPharma, Inc. over the last ten years is 0.82. The current 0.34 Current Ratio has changed 4.06% with respect to the historical average. Over the past ten years (40 quarters), ABVC's Current Ratio was at its highest in in the March 2016 quarter at 152.48. The Current Ratio was at its lowest in in the December 2014 quarter at 0.
Average
0.82
Median
0.23
Minimum
0
Maximum
3.07
Discovering the peaks and valleys of ABVC BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 3.07
Minimum Annual Increase = -100.00%
Minimum Annual Current Ratio = 0
Year | Current Ratio | Change |
---|---|---|
2023 | 0.28 | -45.60% |
2022 | 0.51 | -80.31% |
2021 | 2.61 | 104.58% |
2020 | 1.27 | 888.68% |
2019 | 0.13 | 645.44% |
2018 | 0.02 | -90.71% |
2017 | 0.19 | -93.94% |
2016 | 3.07 | 3.21% |
2015 | 0.09 | Infinity% |
2014 | 0 | -100.00% |
The current Current Ratio of ABVC BioPharma, Inc. (ABVC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.13
5-year avg
0.96
10-year avg
0.82
ABVC BioPharma, Inc.’s Current Ratio is less than Indaptus Therapeutics, Inc. (3.42), less than Pasithea Therapeutics Corp. (14.81), less than Better Therapeutics, Inc. (0.57), less than Forte Biosciences, Inc. (2.06), less than Evelo Biosciences, Inc. (0.48), less than Aptinyx Inc. (10.18), less than Magenta Therapeutics, Inc. (14.64), less than Aileron Therapeutics, Inc. (3.30), greater than Aridis Pharmaceuticals, Inc. (0.24), greater than Akari Therapeutics, Plc (0.29), greater than Aditxt, Inc. (0.09), less than Acasti Pharma Inc. (7.86), less than RenovoRx, Inc. (5.40), less than Anebulo Pharmaceuticals, Inc. (3.45), less than SAB Biotherapeutics, Inc. (3.69), less than Monopar Therapeutics Inc. (5.41K), less than Eledon Pharmaceuticals, Inc. (6.53), less than Nutriband Inc. (6.57), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Longeveron Inc. (7.67), less than Virax Biolabs Group Limited (25.94),
Company | Current Ratio | Market cap |
---|---|---|
3.42 | $10.20M | |
14.81 | $3.93M | |
0.57 | $5.45K | |
2.06 | $23.39M | |
0.48 | $28.47K | |
10.18 | $0 | |
14.64 | $42.44M | |
3.30 | $53.51M | |
0.24 | $4.46K | |
0.29 | $18.72M | |
0.09 | $4.82M | |
7.86 | $34.17M | |
5.40 | $30.96M | |
3.45 | $37.86M | |
3.69 | $28.89M | |
5.41K | $106.08M | |
6.53 | $239.55M | |
6.57 | $53.42M | |
3.02 | $2.95M | |
7.67 | $28.04M | |
25.94 | $8.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABVC BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABVC BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ABVC BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for ABVC BioPharma, Inc. (ABVC)?
What is the highest Current Ratio for ABVC BioPharma, Inc. (ABVC)?
What is the 3-year average Current Ratio for ABVC BioPharma, Inc. (ABVC)?
What is the 5-year average Current Ratio for ABVC BioPharma, Inc. (ABVC)?
How does the current Current Ratio for ABVC BioPharma, Inc. (ABVC) compare to its historical average?